{"id":"https://openalex.org/W2103274121","doi":"https://doi.org/10.2337/dc14-1984","title":"Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial","display_name":"Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial","alternate_titles":[],"publication_year":2015,"publication_date":"2015-04-17","ids":{"openalex":"https://openalex.org/W2103274121","doi":"https://doi.org/10.2337/dc14-1984","mag":"2103274121","pmid":"https://pubmed.ncbi.nlm.nih.gov/25887358"},"language":"en","primary_location":{"id":"doi:10.2337/dc14-1984","doi":"https://doi.org/10.2337/dc14-1984","is_oa":false,"landing_page_url":"https://doi.org/10.2337/dc14-1984","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103274121"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002832666","display_name":"Juris Jendrik Meier","orcid":"https://orcid.org/0000-0002-5835-8019","observed_orcids":["https://orcid.org/0000-0002-5835-8019"]},"institutions":[{"id":"https://openalex.org/I4210138993","display_name":"St. Josef-Hospital","ror":"https://ror.org/046vare28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210138993","https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Juris J. Meier","raw_affiliation_strings":["Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany","1Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"]},{"raw_affiliation_string":"1Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio Rosenstock","raw_affiliation_strings":["Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX","institution_ids":["https://openalex.org/I2800474951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072715151","display_name":"Agn\u00e8s Hincelin-M\u00e9ry","orcid":"https://orcid.org/0009-0000-7827-0789","observed_orcids":["https://orcid.org/0009-0000-7827-0789"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Agn\u00e8s Hincelin-M\u00e9ry","raw_affiliation_strings":["Sanofi R&D, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi R&D, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009161997","display_name":"Christine Roy-Duval","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christine Roy-Duval","raw_affiliation_strings":["Sanofi R&D, Chilly-Mazarin, France","3Sanofi R&D, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi R&D, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]},{"raw_affiliation_string":"3Sanofi R&D, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012829925","display_name":"Astrid Delfolie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Astrid Delfolie","raw_affiliation_strings":["Sanofi R&D, Chilly-Mazarin, France","3Sanofi R&D, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi R&D, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]},{"raw_affiliation_string":"3Sanofi R&D, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112477463","display_name":"Hans Veit Coester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165534","display_name":"Profil Institute for Metabolic Research","ror":"https://ror.org/05krxy197","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210165534"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans-Veit Coester","raw_affiliation_strings":["Profil, Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil, Neuss, Germany","institution_ids":["https://openalex.org/I4210165534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111991123","display_name":"Bjoern A. Menge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138993","display_name":"St. Josef-Hospital","ror":"https://ror.org/046vare28","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210138993","https://openalex.org/I4210153564"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bjoern A. Menge","raw_affiliation_strings":["Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Division, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany","institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044778195","display_name":"Thomas M. Forst","orcid":"https://orcid.org/0000-0003-2132-5691","observed_orcids":["https://orcid.org/0000-0003-2132-5691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Forst","raw_affiliation_strings":["Profil, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil, Mainz, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068619321","display_name":"Christoph Kapitza","orcid":"https://orcid.org/0000-0002-9700-2373","observed_orcids":["https://orcid.org/0000-0002-9700-2373"]},"institutions":[{"id":"https://openalex.org/I4210165534","display_name":"Profil Institute for Metabolic Research","ror":"https://ror.org/05krxy197","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210165534"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Kapitza","raw_affiliation_strings":["Profil, Neuss, Germany","4Profil, Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil, Neuss, Germany","institution_ids":["https://openalex.org/I4210165534"]},{"raw_affiliation_string":"4Profil, Neuss, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5002832666"],"corresponding_institution_ids":["https://openalex.org/I4210138993","https://openalex.org/I904495901"],"apc_list":null,"apc_paid":null,"fwci":24.6846,"has_fulltext":false,"cited_by_count":283,"citation_normalized_percentile":{"value":0.99818079,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"38","issue":"7","first_page":"1263","last_page":"1273"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lixisenatide","display_name":"lixisenatide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9409999847412109},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9300000071525574},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/postprandial-glycemic-control","display_name":"postprandial glucose control","score":0.8610000014305115},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.9570000171661377},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5669999718666077},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7400000095367432},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8080000281333923},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.5910000205039978},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.906000018119812},{"id":"https://openalex.org/keywords/amylase-and-lipase","display_name":"amylase and lipase","score":0.796999990940094},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6510000228881836},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.33799999952316284},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8992177248001099},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.877183735370636},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8687141537666321},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.7601324915885925},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.7265779376029968},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7188159227371216},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6698369979858398},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6638030409812927},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6534515619277954},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.60407555103302},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5544388890266418},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5094977021217346},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4547998905181885},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4214276671409607},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.41293907165527344},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3344210982322693},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.06263688206672668}],"mesh":[{"descriptor_ui":"D000067758","descriptor_name":"Glucagon-Like Peptide-2 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005746","descriptor_name":"Gastric Emptying","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019518","descriptor_name":"Postprandial Period","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2337/dc14-1984","doi":"https://doi.org/10.2337/dc14-1984","is_oa":false,"landing_page_url":"https://doi.org/10.2337/dc14-1984","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:25887358","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25887358","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1584571461","https://openalex.org/W1966748421","https://openalex.org/W1967854294","https://openalex.org/W1977102586","https://openalex.org/W1984128009","https://openalex.org/W1984640659","https://openalex.org/W1994492457","https://openalex.org/W2002757015","https://openalex.org/W2005778725","https://openalex.org/W2023623030","https://openalex.org/W2032998015","https://openalex.org/W2034769818","https://openalex.org/W2035920774","https://openalex.org/W2045188930","https://openalex.org/W2056494500","https://openalex.org/W2063337698","https://openalex.org/W2071835038","https://openalex.org/W2073977794","https://openalex.org/W2089652721","https://openalex.org/W2090244618","https://openalex.org/W2098459806","https://openalex.org/W2103903409","https://openalex.org/W2106709036","https://openalex.org/W2107074825","https://openalex.org/W2108122035","https://openalex.org/W2109677274","https://openalex.org/W2111765225","https://openalex.org/W2111876001","https://openalex.org/W2113367996","https://openalex.org/W2126781806","https://openalex.org/W2127454519","https://openalex.org/W2135064706","https://openalex.org/W2135692247","https://openalex.org/W2137352234","https://openalex.org/W2138290933","https://openalex.org/W2139562487","https://openalex.org/W2140952918","https://openalex.org/W2150012656","https://openalex.org/W2153627384","https://openalex.org/W2154433510","https://openalex.org/W2157103773","https://openalex.org/W2160001758","https://openalex.org/W2170606300","https://openalex.org/W2170897377","https://openalex.org/W2172193326","https://openalex.org/W2409814879","https://openalex.org/W2510708214","https://openalex.org/W2769264260","https://openalex.org/W2789732774","https://openalex.org/W4252759459"],"related_works":["https://openalex.org/W2045188930","https://openalex.org/W1966748421","https://openalex.org/W2991825660","https://openalex.org/W3031720908","https://openalex.org/W2074868663","https://openalex.org/W4224249367","https://openalex.org/W2443999297","https://openalex.org/W2943099799","https://openalex.org/W2581477652","https://openalex.org/W3041477129"],"abstract_inverted_index":{"OBJECTIVE:":[0],"This":[1,30],"mechanistic":[2],"trial":[3,37],"compared":[4,144],"the":[5,76],"pharmacodynamics":[6],"and":[7,11,42,45,111,115,118,132,168,188,201,239,251,254,314,333,349],"safety":[8,351],"of":[9,140,290,347],"lixisenatide":[10,39,248,285],"liraglutide":[12,43,146,165,180,199,252,262,312,334],"in":[13,21,53,72,95,213,338],"combination":[14,54],"with":[15,55,145,198,284,295,302,311,344],"optimized":[16,59,339],"insulin":[17,56,340],"glargine":[18,57],"with/without":[19],"metformin":[20],"type":[22],"2":[23],"diabetes":[24],"(T2D).":[25],"RESEARCH":[26],"DESIGN":[27],"AND":[28],"METHODS:":[29],"was":[31,65,191,211,224,293],"a":[32,85,194],"multicenter,":[33],"randomized,":[34],"open-label,":[35],"three-arm":[36],"comparing":[38],"20":[40,135,249],"\u00b5g":[41,136,250],"1.2":[44,166,200,253,313],"1.8":[46,181,202,255,315],"mg":[47,167,203,316],"once":[48],"daily":[49],"for":[50,81,186,207,247,326],"8":[51,71],"weeks":[52],"after":[58,84],"titration.":[60],"The":[61],"primary":[62],"end":[63],"point":[64],"change":[66],"from":[67,93,272,309],"baseline":[68,94,273,310],"to":[69,193],"week":[70,218,259],"incremental":[73],"area":[74],"under":[75],"postprandial":[77],"plasma":[78,99,104],"glucose":[79,100,105],"curve":[80],"4":[82,237,245],"h":[83,143,156,161,171,176],"standardized":[86],"solid":[87],"breakfast":[88],"(AUC":[89],"PPG0030-0430":[90,142],"h).":[91],"Changes":[92],"gastric":[96,189],"emptying,":[97],"24-h":[98,107,269],"profile,":[101],"HbA1c,":[102],"fasting":[103],"(FPG),":[106],"ambulatory":[108],"heart":[109,270],"rate":[110,271],"blood":[112],"pressure,":[113],"amylase":[114],"lipase":[116],"levels,":[117],"adverse":[119],"events":[120],"(AEs)":[121],"were":[122,130,299,306],"also":[123],"assessed.":[124],"RESULTS:":[125],"In":[126],"total,":[127],"142":[128],"patients":[129],"randomized":[131],"treated.":[133],"Lixisenatide":[134,332],"achieved":[137],"greater":[138,195],"reductions":[139],"AUC":[141],"(marginal":[147,317],"mean":[148,220,266,318],"[95%":[149],"one-sided":[150],"CI]":[151],"treatment":[152,208,215],"difference,":[153],"-6.0":[154],"[-7.8]":[155],"\u22c5":[157,162,172,177],"mmol/L":[158,173],"[-108.3":[159],"(-140.0)":[160],"mg/dL]":[163,178],"vs.":[164,179,279],"-4.6":[169],"[-6.3]":[170],"[-83.0":[174],"(-114.2)":[175],"mg;":[182],"P":[183,328],"<":[184,205,287,329],"0.001":[185,206],"both),":[187],"emptying":[190],"delayed":[192],"extent":[196],"than":[197],"(P":[204,286],"comparisons).":[209],"FPG":[210],"unchanged":[212],"all":[214],"arms.":[216],"At":[217,258],"8,":[219,260],"\u00b1":[221,226,229,233,236,241,244,267,276,281,319,323],"SD":[222],"HbA1c":[223],"6.2":[225],"0.4%":[227],"(44":[228,235,243],"5":[230],"mmol/mol),":[231,238],"6.1":[232,240],"0.3%":[234,242],"mmol/mol)":[246],"mg,":[256],"respectively.":[257],"both":[261],"doses":[263],"increased":[264,308],"marginal":[265],"SE":[268,320],"by":[274],"9":[275],"1":[277,282],"bpm":[278,283],"3":[280],"0.001).":[288],"Occurrence":[289],"symptomatic":[291],"hypoglycemia":[292],"higher":[294],"lixisenatide;":[296],"gastrointestinal":[297],"AEs":[298],"more":[300],"common":[301],"liraglutide.":[303],"Lipase":[304],"levels":[305],"significantly":[307],"increase":[321],"21":[322],"7":[324],"IU/L":[325],"both;":[327],"0.05).":[330],"CONCLUSIONS:":[331],"improved":[335],"glycemic":[336],"control":[337],"glargine-treated":[341],"T2D":[342],"albeit":[343],"contrasting":[345],"mechanisms":[346],"action":[348],"differing":[350],"profiles.":[352]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103274121","counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":27},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":23},{"year":2019,"cited_by_count":27},{"year":2018,"cited_by_count":29},{"year":2017,"cited_by_count":39},{"year":2016,"cited_by_count":39},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
